Literature DB >> 15882905

Coats' disease diagnosed in adulthood.

Lindsay M Smithen1, Gary C Brown, Alexander J Brucker, Lawrence A Yannuzzi, Christina M Klais, Richard F Spaide.   

Abstract

PURPOSE: To investigate the manifestations and clinical course of Coats' disease diagnosed in adulthood and to describe the characteristics of patients who develop it.
DESIGN: Retrospective observational case series. PARTICIPANTS: Thirteen eyes of 13 patients with Coats' disease diagnosed after age 35 years.
METHODS: All patients examined in the authors' referral practices for Coats' disease diagnosed after the age of 35 years were identified. Patients with a history of radiation exposure, intraocular inflammation, retinal vascular occlusion, or Coats' response were excluded. A review of their historical, clinical, and fluorescein angiographic features and demographics was performed.
RESULTS: There were 13 patients with a mean age at diagnosis of 50 years (range, 36-79) and a mean follow-up of 5.8 years (range, 0-17). These patients manifested many findings typical of Coats' disease, including the unilateral nature of the disease (13/13 patients), male predominance (12/13), vascular telangiectasis, lipid exudation, macular edema, and areas of capillary nonperfusion with adjacent webs of filigreelike capillaries. Disease was limited to < or =6 clock hours in 10 of 13 patients (76.9%), did not generally involve the retinal vasculature anterior to the equator, and showed limited potential to expand during the follow-up period. A localized hemorrhage was noted in 10 of 13 patients (76.9%), almost always near larger aneurysmal dilatations. Limited exudative detachment of the retina was seen in 4 eyes, 3 of which responded to localized laser photocoagulation. One patient had subretinal fluid seen on ocular coherence tomography that did not require treatment. On average, patients lost 2.1 lines of visual acuity during the follow-up period; 6 patients had a decline in vision, 2 patients had improved vision, and 3 patients had stable vision. No patient had end-stage findings of Coats' disease, such as iris neovascularization or total exudative detachment.
CONCLUSIONS: Coats' disease can first be diagnosed in adulthood with retinal vascular abnormalities similar to those seen in younger patients. There are a number of important differences in disease manifestation in adults, including limited area of involvement, slower apparent progression of disease, and hemorrhage near larger vascular dilatations.

Entities:  

Mesh:

Year:  2005        PMID: 15882905     DOI: 10.1016/j.ophtha.2004.12.038

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  33 in total

1.  Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.

Authors:  Saemi Park; Han Joo Cho; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-03       Impact factor: 3.117

2.  Intravitreal ranibizumab in the management of stage 2B Coats disease in a young adult Malay man.

Authors:  Swee Sew Teh; Amin Ahem; Mae-Lynn Catherine Bastion
Journal:  BMJ Case Rep       Date:  2013-06-16

3.  Role of intravitreal bevacizumab in adult onset Coats' disease.

Authors:  Neha Goel; Vinod Kumar; Anisha Seth; Usha Kaul Raina; Basudeb Ghosh
Journal:  Int Ophthalmol       Date:  2011-03-25       Impact factor: 2.031

4.  Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.

Authors:  Saemi Park; Han Joo Cho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-07       Impact factor: 3.117

5.  Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.

Authors:  Kshitiz Kumar; Pallavi Raj; Nisha Chandnani; Amar Agarwal
Journal:  Int Ophthalmol       Date:  2018-01-29       Impact factor: 2.031

Review 6.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

7.  Coats' disease: an Indian perspective.

Authors:  Pukhraj Rishi; Ekta Rishi; Mahesh Uparkar; Tarun Sharma; Lingam Gopal; Pramod Bhende; Muna Bhende; Pratik Ranjan Sen; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

8.  Combined photodynamic therapy and intravitreal bevacizumab injection for the treatment of adult Coats' disease: a case report.

Authors:  Jongshin Kim; Kyu Hyung Park; Se Joon Woo
Journal:  Korean J Ophthalmol       Date:  2010-11-23

9.  The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.

Authors:  Xiao-Xue Zheng; Yan-Rong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-20       Impact factor: 3.117

10.  Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.

Authors:  Jong Hwa Jun; Yu Cheol Kim; Kwang Soo Kim
Journal:  Korean J Ophthalmol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.